Compare Monster Beverage Corp (MNST) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Monster Beverage Corp vs Smith & Nephew plc — how do they compare? Monster Beverage Corp trades at $42.94 (market cap $83.93B), while Smith & Nephew plc trades at $27.96 (market cap $11.62B). The key difference: Monster Beverage Corp is far larger — about 7.2× Smith & Nephew plc's market cap, and Smith & Nephew plc pays a 2.86% dividend while Monster Beverage Corp pays none. Which is the better fit depends on your goals.
| MNST | SNN | |
|---|---|---|
Market Cap | $83.93B | $11.62B |
Sector | Consumer Staples | Health |
52-Week High | $49.97 | $38.53 |
52-Week Low | $31.41 | $27.80 |
Enterprise Value | $82.22B | $14.66B |
Dividend Yield | — | 2.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Monster Beverage (MNST) trades at $43.15, down 1.53% on the day, following a recent 2-for-1 stock split completed in August 2026. The stock exhibits a bullish technical signal from oscillators despite bearish moving averages, with key support at $42. Fundamentally, the company reported strong Q2 2026 earnings, beating estimates with $0.30 EPS, and shows robust revenue growth, with 2025 revenue reaching $8.29 billion and net income of $1.91 billion. Profitability remains high, with a net margin of 23.08% and ROE of 25.7%.
The outlook for MNST is positive, driven by consistent earnings beats, international expansion accounting for 46% of sales, and analyst consensus favoring a buy rating with a $51.10 price target. Key risks include elevated valuation multiples, such as a P/E of 39.95, and competitive pressures in the energy drink sector. Investors should weigh growth prospects against premium pricing.
SNN trades at $27.87, down 3.46% today and near a 52-week low. Technical indicators are bearish, but oversold RSI levels suggest potential for a rebound. Fundamentally, the company shows strong revenue growth to $6.16 billion in 2025 and a net income margin of 10.08%, though recent guidance cuts and CFO departure have weighed on sentiment. A dividend of $0.31 is scheduled for payment in November 2026.
The outlook is cautious due to competitive pressures and execution risks, but valuation metrics like a P/E of 18.96 appear reasonable. Analyst consensus is Hold, with 65% recommending neutrality. Upside depends on improved operational performance and stabilization in key markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Monster Beverage Corp
Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
